SCYNEXIS Inc (SCYX)
1.565
-0.06
(-3.99%)
USD |
NASDAQ |
Sep 20, 16:00
1.56
0.00 (0.00%)
After-Hours: 20:00
SCYNEXIS Free Cash Flow: -10.18M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -10.18M |
| March 31, 2024 | 75.08M |
| December 31, 2023 | 60.16M |
| September 30, 2023 | 45.09M |
| June 30, 2023 | 10.16M |
| March 31, 2023 | -82.82M |
| December 31, 2022 | -79.89M |
| September 30, 2022 | -83.19M |
| June 30, 2022 | -77.60M |
| March 31, 2022 | -70.77M |
| December 31, 2021 | -55.73M |
| September 30, 2021 | -46.20M |
| June 30, 2021 | -39.15M |
| March 31, 2021 | -36.26M |
| December 31, 2020 | -49.36M |
| September 30, 2020 | -46.24M |
| June 30, 2020 | -46.78M |
| March 31, 2020 | -45.68M |
| December 31, 2019 | -38.12M |
| September 30, 2019 | -30.81M |
| June 30, 2019 | -26.62M |
| March 31, 2019 | -27.16M |
| Date | Value |
|---|---|
| December 31, 2018 | -28.89M |
| September 30, 2018 | -27.90M |
| June 30, 2018 | -26.93M |
| March 31, 2018 | -26.01M |
| December 31, 2017 | -24.56M |
| September 30, 2017 | -23.96M |
| June 30, 2017 | -25.57M |
| March 31, 2017 | -27.18M |
| December 31, 2016 | -29.38M |
| September 30, 2016 | -30.85M |
| June 30, 2016 | -29.75M |
| March 31, 2016 | -29.39M |
| December 31, 2015 | -25.13M |
| September 30, 2015 | -20.90M |
| June 30, 2015 | -19.13M |
| March 31, 2015 | -14.98M |
| December 31, 2014 | -10.18M |
| September 30, 2014 | -9.772M |
| June 30, 2014 | -5.983M |
| March 31, 2014 | -2.534M |
| December 31, 2013 | -4.738M |
Free Cash Flow Range, Past 5 Years
-83.19M
Minimum
Sep 2022
75.08M
Maximum
Mar 2024
-32.41M
Average
-45.94M
Median
Free Cash Flow Benchmarks
| Inogen Inc | -19.72M |
| NovaBay Pharmaceuticals Inc | -3.396M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.67M |
| Theriva Biologics Inc | -18.01M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.86M |
| Cash from Investing (Quarterly) | 1.372M |
| Free Cash Flow Per Share (Quarterly) | -0.2239 |
| Free Cash Flow to Equity (Quarterly) | -23.64M |
| Free Cash Flow to Firm (Quarterly) | -10.86M |
| Free Cash Flow Yield | -13.49% |